AbbVie says Phase 3 studies show continued repigmentation with Rinvoq through week 76
ABBV•AbbVie said Phase 3 studies showed continued repigmentation with Rinvoq through week 76. Rinvoq combined with NB-UVB showed higher repigmentation than Rinvoq alone.
1. Study findings
AbbVie said Phase 3 studies showed continued repigmentation with Rinvoq through week 76, and that Rinvoq plus NB-UVB showed higher repigmentation than Rinvoq alone.
